Literature DB >> 32559670

Predicting Alzheimer's disease based on survival data and longitudinally measured performance on cognitive and functional scales.

Yan Wu1, Xinnan Zhang1, Yao He1, Jing Cui1, Xiaoyan Ge1, Hongjuan Han1, Yanhong Luo1, Long Liu1, Xuxia Wang1, Hongmei Yu2.   

Abstract

This study assessed how well longitudinally taken cognitive and functional scales from people with mild cognitive impairment (MCI) predict conversion to Alzheimer's disease (AD). Participants were individuals with baseline MCI from the Alzheimer's Disease Neuroimaging Initiative. Scales included the Alzheimer Disease Assessment Scale-Cognitive (ADAS-Cog) 11 and 13, the Mini Mental State Examination (MMSE), and the Functional Assessment Questionnaire (FAQ). A joint modelling approach compared performance on the four scales for dynamic prediction of risk for AD. The goodness of fit measures included log likelihood, the Akaike Information Criterion (AIC) and the Bayesian Information Criterion (BIC). The area under the curve (AUC) of the receiver operating characteristic assessed predictive accuracy. The parameter α in the ADAS-Cog11, ADAS-Cog13, MMSE, and FAQ joint models was statistically significant. Joint MMSE and FAQ models had better goodness of fit. FAQ had the best predictive accuracy. Cognitive and functional impairment assessment scales are strong screening predictors when repeated measures are available. They could be useful for predicting risk for AD in primary healthcare.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; Joint modeling; Predictive performance; Primary screening

Mesh:

Year:  2020        PMID: 32559670     DOI: 10.1016/j.psychres.2020.113201

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  4 in total

Review 1.  Disease Modelling of Cognitive Outcomes and Biomarkers in the European Prevention of Alzheimer's Dementia Longitudinal Cohort.

Authors:  James Howlett; Steven M Hill; Craig W Ritchie; Brian D M Tom
Journal:  Front Big Data       Date:  2021-08-20

2.  A workflow for the joint modeling of longitudinal and event data in the development of therapeutics: Tools, statistical methods, and diagnostics.

Authors:  Kirill Zhudenkov; Sergey Gavrilov; Alina Sofronova; Oleg Stepanov; Nataliya Kudryashova; Gabriel Helmlinger; Kirill Peskov
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2022-02-21

Review 3.  Machine learning for modeling the progression of Alzheimer disease dementia using clinical data: a systematic literature review.

Authors:  Sayantan Kumar; Inez Oh; Suzanne Schindler; Albert M Lai; Philip R O Payne; Aditi Gupta
Journal:  JAMIA Open       Date:  2021-08-02

4.  Screening and predicting progression from high-risk mild cognitive impairment to Alzheimer's disease.

Authors:  Xiao-Yan Ge; Kai Cui; Long Liu; Yao Qin; Jing Cui; Hong-Juan Han; Yan-Hong Luo; Hong-Mei Yu
Journal:  Sci Rep       Date:  2021-09-02       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.